The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPEL.L Regulatory News (PEL)

  • There is currently no data for PEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

29 Sep 2011 16:55

RNS Number : 2358P
Marwyn Capital II Limited
29 September 2011
 



The Directors are pleased to present the interim results of Marwyn Capital II Limited for the 6 month period to 30 June 2011.

 

Acquisition strategy

Marwyn Capital II Limited was established to acquire one or more quoted or unquoted businesses or companies (in whole or in part) initially by way of a reverse takeover. The Company was admitted to London's Alternative Investment Market ('AIM') in December 2009. The Company is seeking an acquisition wholly or mainly in the UK in the healthcare, testing and inspection and leisure sectors.

 

Results

The Group's loss after taxation for the 6 month period to 30 June 2011 was £866,724 (2010: £383,569) which was in line with the expected result for the period. As at 30 June 2011, the Group had net cash balances totalling £3.3m (2010: £4.4m).

 

Dividends

It is the board's policy that prior to making the first acquisition, no dividends will be paid. Following the first acquisition, subject to availability of distributable reserves, dividends will be paid to shareholders when the directors believe it is appropriate and prudent to do so. However, the main focus of the Company will be on delivering capital growth for shareholders.

 

Outlook

In the period since the release of the Company's annual results, the Company has continued to pursue its stated strategy. Accordingly, the Board of Directors (the "Board") continue to review potential acquisition opportunities for the Company and monitor and control its planned levels of expenditure in the pre-acquisition phase.

 

 

 

For the 6 month period to 30 June 2011

 

 

6 months to 30 June 2011 (unaudited)

 

 

From incorporation to 30 June 2010 (unaudited)

 

 

£

 

 

£

 

 

 

 

 

 

Revenue

 

-

 

 

-

 

 

 

 

 

 

Professional and consultancy expenses

 

734,894

 

 

347,771

Other expenses

 

131,830

 

 

35,798

 

 

866,724

 

 

383,569

 

 

 

 

 

 

Loss from operating activities

 

866,724

 

 

383,569

 

 

 

 

 

 

Loss before income tax

 

866,724

 

 

383,569

 

 

 

 

 

 

Income tax expense

 

-

 

 

-

Loss for the period

 

866,724

 

 

383,569

 

 

 

 

 

 

Total comprehensive loss for the period

 

866,724

 

 

383,569

 

 

 

 

 

 

Attributable to:

 

 

 

 

 

Owners of the Group

 

866,724

 

 

383,569

Total comprehensive loss for the period

 

866,724

 

 

383,569

 

 

 

 

 

 

Earnings per share

 

 

 

 

 

Basic and diluted loss per share

 

1.77p

 

 

0.87p

 

 

 

 

 

 

 

30 June 2011 (unaudited)

 

 

31 December 2010

(unaudited)

 

 

£

 

 

 

£

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Prepayments and receivables

 

4,013

 

 

 

8,587

Cash and cash equivalents

 

3,304,861

 

 

 

3,912,902

Current assets

 

3,308,874

 

 

 

3,921,489

Total assets

 

3,308,874

 

 

 

3,921,489

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

Share capital

 

49,000

 

 

 

49,000

Share premium

 

4,665,094

 

 

 

4,665,094

Accumulated losses

 

(1,692,436)

 

 

 

(825,712)

Equity attributable to the owners of the Company

 

3,021,658

 

 

 

3,888,382

Total equity

 

3,021,658

 

 

 

3,888,382

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

Trade and other payables

 

287,214

 

 

 

33,107

Current liabilities

 

287,214

 

 

 

33,107

Total liabilities

 

287,214

 

 

 

33,107

Total equity and liabilities

 

3,308,874

 

 

 

3,921,489

 

 

The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2011.

 

 

 

 

 

For the 6 month period to 30 June 2011 (unaudited)

 

 

Share capital

Share premium

Accumulated losses

Total

 

£

£

£

£

Balance at 1 January 2011

49,000

4,665,094

(825,712)

3,888,382

Total comprehensive loss in the period

-

-

(866,724)

(866,724)

Contribution of equity, net of issue costs

-

-

-

-

Balance at 30 June 2011

49,000

4,665,094

(1,692,436)

3,021,658

 

 

 

For the period from incorporation to 30 June 2010 (unaudited)

 

 

Share capital

Share premium

Accumulated losses

Total

 

£

£

£

£

Balance at incorporation

-

-

-

-

Total comprehensive loss in the period

-

-

(383,569)

(383,569)

Contribution of equity, net of issue costs

49,000

4,665,094

-

4,714,094

Balance at 30 June 2010

49,000

4,665,094

(383,569)

4,330,525

 

 

 

 

 

For the 6 month period to 30 June 2010

 

6 month period to 30 June 2011

(unaudited)

 

 

From incorporation to 30 June 2010

(unaudited)

 

 

 

£

 

 

£

 

 

 

 

 

 

 

Cash flow from operating activities:

 

 

 

 

 

 

Payments to suppliers

 

 

(608,041)

 

 

(296,470)

Net cash outflow from operating activities

 

 

(608,041)

 

 

(296,470)

 

 

 

 

 

 

 

Cash flow from financing activity:

 

 

 

 

 

 

Equity issued, net of issue costs

 

 

-

 

 

4,714,094

Net cash flow from financing activity

 

 

-

 

 

4,714,094

 

 

 

 

 

 

 

Net (decrease)/increase in cash and cash equivalents

 

 

(608,041)

 

 

4,417,624

Cash and cash equivalents brought forward

 

 

3,912,902

 

 

-

Cash and cash equivalents at 30 June

 

 

3,304,861

 

 

4,417,624

 

 

 

 

 

1. Reporting entity

Marwyn Capital II Limited (the "Company") is an exempted company limited by shares and domiciled in the Cayman Islands. The address of the Company's registered office is PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands. The Company was incorporated on 4 December 2009.

This condensed consolidated interim financial information for the 6 month period to 30 June 2011 comprises the Company and its subsidiary, Marwyn Capital Investments II Limited (together referred to as the "Group" and individually as "Group entities"). The Group is primarily involved in the pursuit of target investments in line with its acquisition strategy.

The Company is listed on AIM.

 

2. Basis of preparation and changes to the Group's accounting policies

 

Basis of preparation

The interim condensed consolidated financial statements for the six months ended 30 June 2011 have been prepared in accordance with IAS 34 Interim Financial Reporting.

The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements, and should be read in conjunction with the Group's annual financial statements as at 31 December 2010.

 

New standards, interpretations and amendments thereof, adopted by the Group

The accounting policies adopted in the preparation of the interim condensed consolidated financial statements are consistent with those followed in the preparation of the Group's annual financial statements for the year ended 31 December 2010, except for the adoption of new standards and interpretations as of 1 January 2011, noted below:

IAS 24 Related Party Transactions (Amendment)

The IASB has issued an amendment to IAS 24 that clarifies the definitions of a related party. The new definitions emphasise a symmetrical view of related party relationships as well as clarifying in which circumstances persons and key management personnel affect related party relationships of an entity. The adoption of the amendment did not have any impact on the financial position or performance of the Group.

IAS 32 Financial Instruments: Presentation (Amendment)

The amendment alters the definition of a financial liability in IAS 32 to enable entities to classify rights issues and certain options or warrants as equity instruments. The amendment is applicable if the rights are given pro rata to all of the existing owners of the same class of an entity's non-derivative equity instruments, to acquire a fixed number of the entity's own equity instruments for a fixed amount in any currency. The amendment has had no effect on the financial position or performance of the Group.

Improvements to IFRSs (issued May 2010)

In May 2010, the IASB issued its third omnibus of amendments to its standards, primarily with a view to removing inconsistencies and clarifying wording. There are separate transitional provisions for each standard. The adoption of the amendments resulting from Improvements to IFRSs to the following standards did not have any impact on the accounting policies, financial position or performance of the Group:

IAS 1 Presentation of Financial Statements: The amendment clarifies that an option to present an analysis of each component of other comprehensive income may be included either in the statement of changes in equity or in the notes to the financial statements.

IFRS 7 Financial Instruments - Disclosures: The amendment was intended to simplify the disclosures provided by reducing the volume of disclosures around collateral held and improving disclosures by requiring qualitative information to put the quantitative information in context.

IAS 34 Interim Financial Statements: The amendment requires additional disclosures for fair values and changes in classification of financial assets, as well as changes to contingent assets and liabilities in interim condensed financial statements.

IFRS 3 Business Combinations - Clarification that contingent consideration arising from business combination prior to adoption of IFRS 3 (as revised in 2008) are accounted for in accordance with IFRS 3 (2005)

IFRS 3 Business Combinations - Unreplaced and voluntarily replaced share-based payment awards and its accounting treatment within a business combination

IAS 27 Consolidated and Separate Financial Statements - applying the IAS 27 (as revised in 2008) transition requirements to consequentially amended standards

IFRIC 13 Customer Loyalty Programmes - in determining the fair value of award credits, an entity shall consider discounts and incentives that would otherwise be offered to customers not participating in the loyalty programme)

The Group has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective.

 

3. Seasonality

The Group does not currently operate in an industry where significant or cyclical variations as a result of seasonal activity are experienced during the financial year.

 

4. Segment information

 

Business segments

The Company raised GBP£4.7m net of expenses through an issue of ordinary shares on its admission to AIM on 24 December 2009. Until such time as an acquisition is made, the Group's sole operation will remain the seeking of a suitable acquisition target. 

 

Geographical segments

Marwyn Capital II Limited is domiciled in the Cayman Islands and administered in Jersey. The Company is seeking an acquisition wholly or mainly in the UK in the healthcare, testing and inspection and leisure sectors.

 

5. Share capital

In December 2009 the Company successfully placed 49m ordinary shares at 10p, raising GBP£4.7m after expenses. The ordinary shares were admitted to trading on AIM on 24 December 2009.

 

6. Earnings per share

 

Basic and diluted earnings per share

The calculation of basic earnings per share of 1.77p loss (2010: 0.87p loss) for the 6 month period to 30 June 2011 was based on the loss attributable to ordinary shareholders of £866,724 (2010: £383,569 loss) and a weighted average number of ordinary shares outstanding of 49,000,000 (2010: 44,288,462).

 

Shares which may be issued in future in connection with the Participation Option are not included in the calculation of weighted average outstanding ordinary shares for the diluted earnings per share calculation as the effect would be anti-dilutive.

 

7. Related parties

 

The Company is listed on AIM and as such there is no controlling party. Marwyn Investment Management LLP is the investment manager to Marwyn Value Investors LP which has a significant shareholding in the Company. Marwyn Investment Management LLP is part of the Marwyn group of companies and the following transactions concern payments and balances with related parties:

 

Marwyn Partners Limited charged £36,000 (2010: £35,250) in respect of rent and £7,181 (2010: £1,361) in respect of recharged expenses during the period. Marwyn Capital LLP charged £75,000 (2010: £90,000) in respect of corporate finance services and £43,689 (2010: £46,335) for recharged expenses during the period. Marwyn Investment Management LLP charged £663,210 (2010: £120,503) in respect of recharged expenses. Axio Capital Solutions Limited charged £12,235 (2010: £9,043) in respect of the administration of the Company during the period.

 

The Company has also entered into a performance participation agreement with Marwyn Management Partners LP (the 'Participation Option'). Marwyn Management Partners LP has been granted an option which may be exercised to subscribe for ordinary shares at an exercise price equal to their nominal value, subject to certain growth and vesting conditions.

 

The number of ordinary shares that may be subscribed for pursuant to the Participation Option is the number that will give Marwyn Management Partners LP a gain equivalent to 10 percent of the increase in shareholder value, being broadly defined as the difference between the market capitalisation of the Company at a point in time and the aggregate placing price of all ordinary shares issued up to that point in time.

 

The Participation Option may only be exercised if both the growth and vesting conditions have been satisfied and will lapse on 24 December 2014.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PGUPABUPGGAB
Date   Source Headline
3rd Jul 20191:15 pmRNSAppointment of Administrators & Nomad Resignation
20th Jun 20196:15 pmRNSParagon Entertainment
20th Jun 20192:00 pmRNSIntention to appoint Administrators
20th Jun 20192:00 pmRNSSuspension - Paragon Entertainment Limited
19th Jun 20199:18 amRNSDismissal of erroneous winding up petition
12th Jun 20197:00 amRNSTrading Update
4th Jun 20197:00 amRNSAppointment of CEO
31st May 20194:47 pmRNSDismissal of winding up petition
31st May 201911:09 amRNSResponse re: Winding up petition
14th Mar 201912:00 pmRNSAppointment of Commercial and Contracts Director
14th Mar 20197:00 amRNSSubscription to raise £150,000
6th Mar 20193:33 pmRNSHolding(s) in Company
6th Mar 201912:20 pmRNSTrading Update
27th Feb 20199:06 amRNSHolding(s) in Company
25th Feb 201912:30 pmRNSContract win
22nd Feb 20191:29 pmRNSProperty Disposal
7th Jan 20199:30 amRNSAnnouncing Dig It! Rostov on Don, Russia opening
18th Dec 20182:15 pmRNSTrading Update
7th Dec 201812:42 pmRNSHolding(s) in Company
12th Oct 20182:55 pmRNSDirector/PDMR Shareholding
1st Oct 20183:49 pmRNSClarification re Notification of Shareholding
1st Oct 20188:33 amRNSNotification of Shareholding
3rd Sep 20187:00 amRNSChange of Chief Executive Officer
22nd Aug 20184:45 pmRNSResult of AGM
22nd Aug 20187:00 amRNSHalf-year Report
31st Jul 20187:00 amRNSDirector Appointment
30th Jul 20187:00 amRNSAnnouncing Dig It! to open in Russia
27th Jul 201812:52 pmRNSNotice of AGM
10th Jul 201810:03 amRNSAnnouncing involvement in KidZania, Abu Dhabi
3rd Jul 20189:16 amRNSOpening of Dig It! in Dubai
29th Jun 201812:43 pmRNSFinal Results
15th May 20185:20 pmRNSWaiver of share option scheme
23rd Apr 20187:00 amRNSTrading Update
5th Feb 20183:35 pmRNSRe Finance Director
3rd Jan 20183:55 pmRNSDirector/PDMR Shareholding
10th Nov 20179:00 amRNSAnchor Partnership with Create Yorkshire
9th Nov 20178:08 amRNSDirector/PDMR Shareholding
7th Nov 20179:05 amRNSSecond Price Monitoring Extn
7th Nov 20179:00 amRNSPrice Monitoring Extension
7th Nov 20177:00 amRNSTrading Update
21st Sep 20173:55 pmRNSDirector/PDMR Shareholding
30th Aug 20177:00 amRNSHalf-year Report
28th Jun 20173:03 pmRNSResult of AGM
28th Jun 20177:00 amRNSDirectorate Change
7th Jun 20178:44 amRNSNotice of Results and AGM
26th Apr 20174:28 pmRNSDirector/PDMR Shareholding
21st Apr 20177:00 amRNSDirector/PDMR Shareholding
20th Apr 20177:00 amRNSFinal Results Statement
1st Feb 20177:00 amRNSConfirmation of Appointment & Holdings in Company
16th Jan 20172:26 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.